Evidence map›Paper›PMID 38464014›Full record

ArticleResearch square2024

Survivin Mediates Mitotic Onset in HeLa Cells Through Activation of the Cdk1-Cdc25B Axis.

Pedro M Cánovas

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Pedro M CánovasDepartment of Cancer Biology, University of Massachusetts, Medical School, Worcester, MA 01605.
University of Massachusetts Chan Medical School · US

Funding

CONTROL OF APOPTOSIS IN CANCER BY SURVIVINR01CA078810 · NCI · YALE UNIVERSITY · PI ALTIERI, DARIO C · 1998 to 2017
$5.5M
Molecular Pathology of Vascular InjuryR37HL054131 · NHLBI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2004 to 2013
$3.1M
Molecular Targeting of the Survivin Pathway in CancerR01CA090917 · NCI · YALE UNIVERSITY · PI ALTIERI, DARIO C · 2001 to 2010
$3.0M
MOLECULAR PATHOLOGY OF VASCULAR INJURYR01HL054131 · NHLBI · YALE UNIVERSITY · PI ALTIERI, DARIO C. · 1994 to 2003
$1.0M
NCI NIH HHS R01 CA078810NCI NIH HHS R01 CA090917NHLBI NIH HHS R01 HL054131NHLBI NIH HHS R37 HL054131
6 · The paper itself

Abstract

The Survivin protein has roles in repairing incorrect microtubule-kinetochore attachments at prometaphase, and the faithful execution of cytokinesis, both as part of the

Indexed as

cancerCdc25BCdk1G2/M-phase checkpointkinasemitosismitotic catastrophephosphataseSurvivin

Identifiers

PMID38464014
PMCPMC10925418
OpenAlexW4392238482

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.